DE2024001C3 - Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch vertragliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel - Google Patents

Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch vertragliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel

Info

Publication number
DE2024001C3
DE2024001C3 DE2024001A DE2024001A DE2024001C3 DE 2024001 C3 DE2024001 C3 DE 2024001C3 DE 2024001 A DE2024001 A DE 2024001A DE 2024001 A DE2024001 A DE 2024001A DE 2024001 C3 DE2024001 C3 DE 2024001C3
Authority
DE
Germany
Prior art keywords
compound
compounds
preparation
acid addition
addition salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2024001A
Other languages
German (de)
English (en)
Other versions
DE2024001B2 (de
DE2024001A1 (de
Inventor
Chiba Ichikawa
Hiroshi Imamura
Tomio Muro
Michio Nakanishi
Oita Nakatsu
Nobuharu Yokohama Kanagawa Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44038137A external-priority patent/JPS4933184B1/ja
Priority claimed from JP45028945A external-priority patent/JPS4943946B1/ja
Priority claimed from JP45028946A external-priority patent/JPS4943947B1/ja
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Publication of DE2024001A1 publication Critical patent/DE2024001A1/de
Publication of DE2024001B2 publication Critical patent/DE2024001B2/de
Application granted granted Critical
Publication of DE2024001C3 publication Critical patent/DE2024001C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2024001A 1969-05-16 1970-05-15 Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch vertragliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel Expired DE2024001C3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP44038137A JPS4933184B1 (enrdf_load_stackoverflow) 1969-05-16 1969-05-16
JP7947769 1969-10-02
JP45028945A JPS4943946B1 (enrdf_load_stackoverflow) 1970-04-03 1970-04-03
JP45028946A JPS4943947B1 (enrdf_load_stackoverflow) 1970-04-03 1970-04-03

Publications (3)

Publication Number Publication Date
DE2024001A1 DE2024001A1 (de) 1970-11-19
DE2024001B2 DE2024001B2 (de) 1979-06-13
DE2024001C3 true DE2024001C3 (de) 1980-02-14

Family

ID=27458978

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2024001A Expired DE2024001C3 (de) 1969-05-16 1970-05-15 Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch vertragliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel

Country Status (7)

Country Link
US (1) US3723476A (enrdf_load_stackoverflow)
AT (1) AT295511B (enrdf_load_stackoverflow)
CA (1) CA956632A (enrdf_load_stackoverflow)
CH (1) CH539630A (enrdf_load_stackoverflow)
DE (1) DE2024001C3 (enrdf_load_stackoverflow)
FR (1) FR2051536B1 (enrdf_load_stackoverflow)
GB (1) GB1262411A (enrdf_load_stackoverflow)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818000A (en) * 1969-01-03 1974-06-18 Cerm Cent Europ Rech Mauvernay 3-alkoxy-or 3-aryloxy-2-(diaryl-hydroxy)-methyl-propylamines
GB1312555A (en) * 1971-02-09 1973-04-04 Ici Ltd Alkanolamine derivatives
FR2173869B1 (enrdf_load_stackoverflow) * 1972-04-13 1975-12-26 Cerm Cent Europ Rech Mauvernay
US4018778A (en) * 1972-05-24 1977-04-19 Cassella Farbwerke Mainkur Aktiengesellschaft Derivatives of 1-phenoxy-3-amino-propane-2-ol and process for their production
LU66207A1 (enrdf_load_stackoverflow) * 1972-09-29 1974-04-02
SE411673B (sv) * 1972-12-22 1980-01-28 Ciba Geigy Ag Forfarande for framstellning av 1-fenoxi-2-hydroxi-3-aminopropaner samt syraadditionssalter derav
AR204334A1 (es) * 1973-01-17 1975-12-22 Ciba Geigy Ag Procedimiento para la elaboracion de compuestos del 1-(4-(alquiltio-alcoxi)-fenoxi)-2-hidroxi-3-alquil-amino-propan
US3991036A (en) * 1973-02-28 1976-11-09 Uniroyal Inc. Preparation of polyurethane using 1,2,3,4,4a,5,7,7a-Octahydrothieno[3,4-b]py
US3940396A (en) * 1973-02-28 1976-02-24 Uniroyal Inc. 1,2,3,4,4A,5,7,7A-Octahydrothieno[3,4-b]pyrazines 6,6-dioxides
CA1046066A (en) * 1973-08-23 1979-01-09 Tomio Muro 1-(methylated piperidino (and pyrrolidin -1-yl)-3-(substituted phenoxy)-2-propanols
LU69043A1 (enrdf_load_stackoverflow) * 1973-12-20 1975-08-20
DE2505423A1 (de) * 1975-02-08 1976-08-19 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4202978A (en) * 1978-02-08 1980-05-13 Hoffmann-La Roche Inc. (S)-1-[2-(4-(2-Hydroxy-s-(1-alkylaminopropoxy)phenylalkyl]-4-phenylpiperazines
DE2914166A1 (de) * 1979-04-07 1980-10-23 Beiersdorf Ag Arylsubstituierte furane und verfahren zu ihrer herstellung
CA1156661A (en) * 1980-02-25 1983-11-08 Hoffmann-La Roche Limited Phenoxy-aminopropanol derivatives
ZW9881A1 (en) * 1980-06-02 1981-12-23 Hoffmann La Roche Substituted phenoxyaminopropanol derivatives
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
HU183721B (en) * 1981-11-06 1984-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing new cyclic imine derivatives
FR2510573B1 (fr) * 1981-07-29 1985-07-26 Carpibem (2-substitue 4-(thienyl acetamido) phenoxy) hydroxy propylamines, leur preparation, leur utilisation en therapeutique, et nouveaux intermediaires
FR2512443A1 (fr) * 1981-09-10 1983-03-11 Synthelabo Derives de phenoxy-3 propanol-2, leur preparation et leur application en therapeutique
JPS5988467A (ja) * 1982-11-09 1984-05-22 Yoshitomi Pharmaceut Ind Ltd フエノキシアミノプロパノ−ル誘導体
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
DE3343671A1 (de) * 1983-12-02 1985-06-20 Basf Ag, 6700 Ludwigshafen Aminopropanolderivate von substituierten 2-hydroxy-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
EP0300290B1 (de) * 1987-07-21 1991-12-18 F. Hoffmann-La Roche Ag Phenoxypropanolamine
CA2314458A1 (en) * 1999-08-02 2001-02-02 Kazumi Okuro Process for production of 3-(3-pyridyl)-1-propanol derivatives
PL375713A1 (en) 2002-08-19 2005-12-12 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JP7128969B2 (ja) 2019-01-18 2022-08-31 アストラゼネカ・アクチエボラーグ Ｐｃｓｋ９阻害剤及びその使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1220440B (de) * 1962-02-14 1966-07-07 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von Derivaten des 1-(o-Bromphenoxy)-2-hydroxy-3-amino-propans und deren Saeureadditionssalzen

Also Published As

Publication number Publication date
CA956632A (en) 1974-10-22
CH539630A (de) 1973-07-31
FR2051536A1 (enrdf_load_stackoverflow) 1971-04-09
US3723476A (en) 1973-03-27
GB1262411A (en) 1972-02-02
DE2024001B2 (de) 1979-06-13
AT295511B (de) 1972-01-10
FR2051536B1 (enrdf_load_stackoverflow) 1973-08-10
DE2024001A1 (de) 1970-11-19

Similar Documents

Publication Publication Date Title
DE2024001C3 (de) Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch vertragliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE1493856B2 (de) 1-aryloxy-3-(n-alkylamino)-2-propanole, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE2556110B2 (de) 2-(3-Alkylamino-2-hydroxypropoxy)-3cyanpyridine, ihre Herstellung und pharmazeutische Verwendung
DE2223184C3 (de) Benzofuranderivate und deren pharmazeutisch vertragliche Säureadditionssalze sowie ein Verfahren zu deren Herstellung und Arzneimittel mit einem Gehalt dieser Verbindungen
DE1670048C3 (de) Neue Norscopolaminderivate
DE2707048C2 (de) 2-Alkyl-3-Benzoyl-Indolizinderivate, Verfahren zu deren Herstellung, sowie diese enthaltende Zusammensetzungen
DE2046043B2 (de) (-)-5-[3-(tert- Buty!amino)-2-hydroxypropoxy] -3,4dihydro-1 (2H)-naphthalinon, Verfahren zu dessen Herstellung und Pharmazeutika auf dessen Basis
DE2711719C2 (de) 3,4-Dihydrocarbostyril-Derivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
DE2745598A1 (de) Arylschwefelverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
DE1925956B2 (de) 4- [3-(subst- Amino)-2-hydroxypropoxy] -1,2,5thiadiazolverbindungen und ein diese Verbindungen enthaltendes pharmazeutisches Mittel
DE3223877C2 (enrdf_load_stackoverflow)
DE2436398A1 (de) Morpholinderivate
DE2257397C3 (de) Decahydrochinolinolderivate, deren Salze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE1545744C (de) Basische Terpenätherderivate
DE1097995B (de) Verfahren zur Herstellung von Phenthiazinderivaten
AT234705B (de) Verfahren zur Herstellung von neuen (4-Alkylpiperazino)-sulfonamiden
DE2265580C2 (de) Heptamethylenimino-alkyl-xanthen-9-carbonsäureester, deren Säureadditionssalze und Verfahren zu deren Herstellung, sowie Arzneimittel, welche diese enthalten
DE2519163C2 (de) 2-Formyl-1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert.butyl-aminopropoxy)-isochinolin, dessen Salze, Verfahren zu deren Herstellung und ihre Verwendung
AT290503B (de) Verfahren zur Herstellung von neuen 1-(4'-Acylaminophenoxy)-2-hydroxy-3-aminopropanen und von deren Säureadditionssalzen
DE2254478A1 (de) Salicylsaeureamide
AT260920B (de) Verfahren zur Herstellung von neuen Benzofuranderivaten und ihren Salzen
AT282586B (de) Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen
AT214428B (de) Verfahren zur Herstellung neuer basischer Phenoläther und ihrer Salze
CH638490A5 (de) Anilide mit hustenhemmender wirkung und verfahren zur herstellung derselben.
DE2200204A1 (de) Verfahren zur Herstellung neuer heterozyklischer Verbindungen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee